FDA’s tobacco program must be proactive, not reactive, independent panel says after extensive review

An independent panel of experts says its review of the US Food and Drug Administration’s tobacco program found numerous wide-ranging problems that hinder its ability to regulate the industry and reduce tobacco-related disease and death.

(SOURCE) https://www.cnn.com/2022/12/19/health/fda-tobacco-review/index.html

Share:


Related Posts

Indonesia, Brazil biggest culprits in tropical forest loss linked to industrial mining: study

Industrial-scale mining for materials such as coal, gold, and iron ore is spurring...

Lincoln's new concept car replaces steering wheel with 'chess piece controller'

Automaker Lincoln revealed its futuristic luxury electric concept car, the Model L100. This...

Leave a Comment

Your email address will not be published. Required fields are marked *

Add Comment *

Name *

Email *

Website